Membership Directory
Galenea Corp.
Category: Drug Development
Phone: + (617) 374-1010 X 2319
Fax: + (617) 374-1320
Website: http://www.galenea.com
Location: Cambridge, MA
Therapeutic Areas: Central nervous system
Galenea is fully integrated drug discovery company focused on psychiatric and neurodegenerative diseases. We have an early clinical program for a 5HT6 antagonist for cognitive impairment. We have a late preclinical program for a 5HT2C agonist for schizophrenia and obesity. And we have a novel, proprietary technology platform in synaptic transmission for a variety of diseases. In addition to our wholly owned programs, we have a strong collaboration with Otsuka Pharmaceuticals for the calcineurin pathway in schizophrenia. This collaboration has been expanded and extended twice, and is now worth $90 million in committed funding over seven years.
Back to list